Markus Werner

Head Search & Evaluation Oncology at Novartis AG

Speaker

Markus is member of the Oncology Leadership team at Novartis and heads Search & Evaluation Oncology for solid tumors and hematology across. This includes partnerships across all development stages from early preclinical to commercial stage in a modality and deal agnostic fashion.

He has a scientific background and PhD in molecular biology and is a BD&L professional with more than 20 years of experience in pharmaceutical collaborations and partnerships.

Prior to his tenure at Novartis, Markus has led the partnering and alliance management teams of Molecular Partners and BioNTech and held various business development positions at Takeda, ratiopharm, Nycomed and Altana Pharma. During those years, his responsibilities spread across the four “BD&L verticals” from search & evaluation, transactions, due diligences to alliance management.

His deal track record covers partnerships across the pharmaceutical value chain from early drug discovery to commercial-stage agreements and includes both in- and out-bound deals as well as equity and asset based transaction in various disease areas.

Markus received his doctorate degrees in bioengineering from the University of Stuttgart.